Slotnik Capital’s Day One Biopharmaceuticals DAWN Stock Holding History

Slotnik Capital’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-166,837	Closed	-$3.58M	–	34
2026 Q1	$3.58M	Buy	+166,837	New	+$2.35M	1.05%	20

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Slotnik Capital's DAWN Position: Q2 2026 in Review

Slotnik Capital sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 166,837 shares — an estimated $3.58M sold.

Slotnik Capital first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $3.58M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Slotnik Capital reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Slotnik Capital sold 166,837 Day One Biopharmaceuticals shares in Q2 2026, an estimated $3.58M.
Slotnik Capital first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Slotnik Capital's Day One Biopharmaceuticals position peaked at $3.58M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Slotnik Capital's 13F filing for Q2 2026, filed 13 Aug 2026.